Targeting CDK9 inhibits the growth of KMT2A-rearranged infant leukemia and demonstrates synergy with menin inhibition
靶向 CDK9 可抑制 KMT2A 重排婴儿白血病的生长,并与 menin 抑制剂表现出协同作用。
期刊:
影响因子:
doi:10.1016/j.bneo.2025.100148
Sharma, Ritul; Zhang, Chunfen; Shah, Ravi; Frigault, Melanie M; Johnson, Amy J; Mangum, David Spencer; Maese, Luke D; Lacayo, Norman J; Narendran, Aru